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http:WHAT THIS PAPER ADDS
Critical limb ischemia (CLI) is frequent and associated with a very poor local and general prognosis. An
experimental model fulﬁlling all CLI characteristics is lacking. This is the ﬁrst study to analyze not only clinical and
perfusion parameters, but also cellular and molecular mechanisms involved in CLI up to 30 days postoperatively.
Clinical and scintigraphic scores conﬁrmed CLI, together with impaired mitochondrial respiration, calcium
retention capacity, and biogenesis. Ischemic muscles also demonstrated increased production of reactive oxygen
species, decreased antioxidant enzymes, and myopathic features. Sequential femoral and iliac arteries ligations
closely mimic human functional, clinical, scintigraphic, and skeletal muscle mitochondrial impairments, and
could allow testing of therapeutic approaches needed in view of the gravity of CLI in humans.Objective: To establish a chronic mouse model of critical limb ischemia (CLI) with in vivo and ex vivo validation,
closely mimicking human pathology.
Methods: Swiss mice (n ¼ 28) were submitted to sequential unilateral femoral (day 0) and iliac (day 4) ligatures.
Ischemia was conﬁrmed by clinical scores (tissue and functional damages) and methoxyisobutylisonitrile (MIBI)
scintigraphies at days 0, 4, 6, 10, 20, and 30. At days 10, 20, and 30, muscle mitochondrial respiration, calcium
retention capacity (CRC), and production of reactive oxygen species (ROS) were investigated, together with
transcripts of mitochondrial biogenesis and antioxidant enzymes. Histological analysis was also performed.
Results: Clinical and functional damage conﬁrmed CLI. MIBI scintigraphies showed hypoperfusion of the ischemic
limb, which remained stable until day 30. Mitochondrial respiration was impaired in ischemic muscles compared
with controls (Vmax ¼ 7.93  0.99 vs. 10.09  2.87 mmol/L O2/minute/mg dry weight [dw]; p ¼ .01), together
with impaired CRC (7.4  1.6 mmol/L minute/mg dw vs. 11.9  0.9 mmol/L minute/mg dw; p < .001) and
biogenesis (41% decrease in peroxisome proliferator-activated receptor gamma coactivator [PGC]-1a, 49%
decrease in PGC-1b, and 41% decrease in nuclear respiratory factor-1). Ischemic muscles also demonstrated
increased production of ROS under electron paramagnetic resonance (0.084  0.029 vs. 0.051  0.031 mmol/L
minute/mg dw; p ¼ .03) and with dihydroethidium staining (3622  604 arbitrary units of ﬂuorescence vs.
1224  324; p < .01), decreased antioxidant enzymes (32% decrease in superoxide dismutase [SOD]1, 41%
decrease in SOD2, and 49% decrease in catalase), and myopathic features (wider range in ﬁber size, rounded
shape, centrally located nuclei, and smaller cross-sectional areas). All defects were stable over time.
Conclusion: Sequential femoral and iliac ligatures closely mimic human functional, clinical, scintigraphic, and
skeletal muscle mitochondrial characteristics, and could prove useful for testing therapeutic approaches.
 2014 European Society for Vascular Surgery. Published by Elsevier Ltd. All rights reserved.
Article history: Received 26 August 2014, Accepted 4 December 2014, Available online 8 January 2015
Keywords: Critical limb ischemia, Scintigraphy mitochondria oxidative stress myopathyrresponding author. A. Lejay, Department of Vascular Surgery and
Transplantation, University Hospital, B.P. 426, 67091 Strasbourg,
.
il address: anne-catherine.lejay@orange.fr (A. Lejay).
-5884/ 2014 European Society for Vascular Surgery. Published by
r Ltd. All rights reserved.
//dx.doi.org/10.1016/j.ejvs.2014.12.010INTRODUCTION
Critical limb ischemia (CLI) deﬁnes an advanced stage of
chronic arterial insufﬁciency describing patients with typical
ischemic rest pain, or patients with ischemic skin lesions,
either ulcers or gangrene.1e4 The term CLI should only be
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deﬁned as the presence of symptoms for >2 weeks.4
Diagnosis of CLI should also only be made in patients
with symptoms attributable to objectively proven arterial
occlusive disease, and veriﬁed by ankle or toe pressure. The
diagnosis of CLI is thus a clinical diagnosis of chronic arterial
disease, but, inevitably, has to be supported by objective
tests, and must have a duration of >2 weeks.4 However,
despite recent advances in surgical and endovascular
techniques, a large number of patients with CLI is not
eligible for these revascularization procedures because of
the anatomic location of the lesions, the extent of the
disease, or extensive comorbidity, largely supporting the
need for adequate experimental models allowing the
testing of new therapeutic approaches.1,4,5
Understanding of the pathophysiology of lower-limb
ischemiaereperfusion has been greatly improved with
both skeletal muscle dysfunction and increased oxidative
stress appearing as major components.6e10 All of these al-
terations should be observed in relevant experimental
models of CLI. Furthermore, notwithstanding that ischemia
induces neoangiogenesis and formation of collateral ves-
selsdshowing that even after femoral artery excision the
perfusion of the limb returns to normal within a few day-
sdstability of the lesions over time should be obtained.11
Models already exist, but result in progressive blood ﬂow
restoration, with complete restoration 7 days after surgery.
Further, these models have not always been fully charac-
terized on a clinical, functional, and pathophysiological ba-
sis, particularly when considering oxidative stress and
mitochondrial functions that are now considered as key
factors in CLI, including in human pathology.12e14
The main objective of the present study was to develop
and comprehensively characterize, both in vivo and ex vivo,
a chronic, stable, and long-lasting established CLI experi-
mental model, closely mimicking human functional, clinical,
and skeletal muscle mitochondrial pathology. Indeed, such a
durable model is currently lacking and may prove useful for
testing therapeutic approaches.MATERIALS AND METHODS
Animals
Male Swiss mice (n ¼ 28) weighing 30e35 g were handled
according to French laws for animal use and care, and in
accordance with the guidelines of the European Community
Council.CLI model
Surgery was performed under general anesthesia. Induction
was conducted in an airtight ventilated chamber with a
mixture of 3% isoﬂurane (Aerrane; Baxter Healthcare,
Maurepas, France) and air. Maintenance of anesthesia was
ensured by spontaneous ventilation through a mask deliv-
ering a mixture of 2% isoﬂurane and air.
Ligation of the right femoral artery was performed
midway between the superﬁcial epigastric artery and thebifurcation of the popliteal and saphenous arteries under
microscope. Three collateral vessels were also ligatured.
Four days later, ligation of the right common iliac artery
0.5 cm distal to its origin, after visualization of the origin of
internal iliac artery, was performed by laparotomy. In this
unilateral ischemia model, the contralateral limb can be
considered as a control.15 The duration of ischemia was
counted from the ﬁrst operation onwards.
Animals were divided into three groups: one group to be
sacriﬁced 10 days after surgery (group 1; n¼ 10); one group
to be sacriﬁced 20 days after surgery (group 2; n ¼ 8), and
one group to be sacriﬁced 30 days after surgery (group 3;
n ¼ 10) in order to study in vivo perfusion, as well as ex vivo
muscle damage over time. Of these 28 mice, one from
group 1 died at day 1 and one from group 3 died at day 4.
Nine mice were then allocated to ex vivo tissue harvest at
day 10, eight at day 20, and nine at day 30.
Chosen outcomes
In order to mimic as closely as possible human pathology
and according to Trans-Atlantic InterSociety Consensus
(TASC II) guidelines, in vivo chosen outcomes were func-
tional signs objectiﬁed by clinical scoresdscanographic ar-
guments proving the hypoperfusion of the ischemic limb,
for >2 weeks. Ex vivo outcomes were alteration of mito-
chondrial function, by decreased mitochondrial respiratory
chain complex activities and calcium retention capacity
(CRC), increased production of reactive oxygen species
(ROS), and alteration of biogenesis and antioxidant system.
In vivo follow-up of clinical and functional damages and of
limb perfusion
Using already established clinical scores, clinical tissue
damage was graded as follows: normal or white aspect of
the limb, toe cyanosis or necrosis, and spontaneous
amputation of a toe (attributed 1, 2, 3, 4, or 5 points,
respectively).16
Functional damage was graded as follows: normal func-
tion of the limb, plantar ﬂexion without toe ﬂexion, no
plantar ﬂexion, and dragging the limb (attributed 0, 1, 2 or 3
points, respectively).16 Clinical scores were assessed at days
0, 4, 6, 10 (n ¼ 26), 20 (n ¼ 17), and 30 (n ¼ 9).
Tissue perfusion was assessed with gamma camera scans
(Gaede MedizinSysteme GmbH, Freiburg im Breisgau, Ger-
many) under general anesthesia, the animals being placed
in a dedicated heating cell (Minerva, Esternay, France).
Scans lasting 15 minutes were performed 30 minutes after
injection of the tracer (methoxyisobutylisonitrile [MIBI]) at
the tail vein, at day 0 (before femoral ligation), day 4 (before
iliac ligation), and at days 6, 10 (n ¼ 26), 20 (n ¼ 17), and 30
(n ¼ 9).
Ex vivo muscle analysis
Nine mice were allocated to ex vivo tissue harvest at day 10,
eight at day 20, and nine mice at day 30. Ischemic and
contralateral gastrocnemius tibialis muscles were collected.
Gastrocnemius muscles were harvested and immediately
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and production of free radicals. Tibialis muscles were frozen
in order to perform histological sections and transcripts
analyses.
Mitochondrial respiratory chain complex activities. The
mitochondrial respiratory chain is made of four complexes
generating electron transfers in order to produce energy.
This activity requires oxygen. The study of mitochondrial
respiratory chain complex activities is a technique based
on the measurement of oxygen consumption in skinned
ﬁbers in order to determine the functional oxidative ca-
pacity of the skeletal muscle in its cellular environment.
Oxygen concentration is measured with a Clark electrode,
and substrates are then added in order to activate or
inhibit the different complexes of the respiratory chain.
Adenosine diphosphate (2 mM) was added in order to
study complex I, III, and IV activity. Succinate (25 mM) was
then added to study complex I, II, III, and IV activity, which
determines the maximal oxidative capacity (Vmax). The
addition of amytal (0.02 mM) subsequently inhibited
complex I, allowing determining vamytal (complex II, III,
and IV activities). The addition of N, N, N0, N0-tetramethyl-
p-phenylenediamine dihydrochloride (TMPD; 0.5 mM) and
ascorbate (0.5 mM) speciﬁcally activated complex IV
(Vtmpd).
CRC. The CRC of gastrocnemius muscle ﬁbers measured by
spectroﬂuorometry is the amount of calcium required to
enable the opening of the mitochondrial transition pore,
leading to apoptosis.17 Calcium pulses (20 mmol/L) were
applied to the skinned gastrocnemius muscle ﬁbers until
calcium release. The number of calcium additions needed to
trigger mitochondrial permeability transition provided the
CRC.
Production of ROS using electron paramagnetic resonance.
Gastrocnemius muscles (1-mm3 fragments) were incubated
with a 1-hydroxy-3-methoxycarbonyl-2, 2, 5, 5-
tetramethylpyrrolidine HCl (CMH) molecular probe, which
is oxidized in the presence of unpaired electrons of ROS. The
amount of oxidized CMH, and thus the amount of free
radicals produced, was measured by the intensity of the
resonance signal.
Histological analysis: muscle structure and ROS produc-
tion. Tibialis muscles were immersed in liquid nitrogen and
stored at 80 C. Muscles were then embedded in parafﬁn,
and 10-mm-thick sections were prepared using a cryostat
microtome, and mounted onto glass slides. Two types of
analyses were subsequently performed: images of slide
specimens stained with hematoxylin and eosin were ac-
quired under bright-ﬁeld microscopy, while other slides
were incubated with 2.5 mM dihydroethidium (DHE). DHE
produces red ﬂuorescence when oxidized to ethidium bro-
mide, mainly by superoxide anion. After staining, sections
were examined under epiﬂuorescence microscope (Nikon
Eclipse E800; Nikon, Tokyo, Japan) and emission signals
recorded.Protein transcripts encoding for mitochondrial biogenesis
and antioxidant defense. The main protein-encoding tran-
scripts involved in mitochondrial biogenesis (peroxisome
proliferator-activated receptor gamma coactivator [PGC]-
1a, PGC-1b, and nuclear respiratory factor [NRF]1) and
antioxidative enzymes (superoxide dismutase [SOD]1,
SOD2, catalase) were analyzed. RNA (2 mg), isolated with
TRIzol Reagent (Invitrogen, Carlsbad, CA, USA), was con-
verted to cDNA with SuperScript II reverse transcriptase
(Invitrogen, Life Technologies, Carlsbad, CA, USA) and hex-
amer primers according to the manufacturer’s instructions.
Quantitative reverse transcription polymerase chain reac-
tion was performed using the QuantiTectTM SYBR Green
PCR kit (Roche, Basel, Switzerland) according to the man-
ufacturer’s instructions.Statistical analysis
Statistical analysis was performed with GraphPad Prism 5
(GraphPad Software, Inc., La Jolla, CA, USA). Results are
expressed as mean  SD. Comparison were assessed using
the nonparametric ManneWhitney test. p-Values <0.05
were considered as indicative of statistical signiﬁcance.
RESULTS
Follow-up of clinical and functional parameters and of limb
perfusion
Clinical and functional damages. Clinical examination
showed tissue damage: toe necrosis in 22 (85%) mice and
cyanosis in 4 (15%) at day 10; toe necrosis in 15 (88%) mice
and cyanosis in 2 (12%) at day 20; and autoamputation in 2
(22%) mice, toe necrosis in ﬁve (56%), and cyanosis in 2
(22%) at day 30. Clinical examination also showed func-
tional damage: 20 (77%) mice dragged the ischemic limb
and 6 (23%) mice could not achieve plantar ﬂexion at day
10, day 20, or day 30 (Fig. 1A, B).
Limb perfusion. MIBI scans showed hypoperfusion of the
ischemic limb, in comparison with control limb and such
hypoperfusion remained stable until day 30 after surgery
(Fig. 1C).Ex vivo muscle analysis
Mitochondrial respiratory chain complex activities. Mito-
chondrial respiration was signiﬁcantly impaired in ischemic
muscles compared with control muscles at days 10, 20, and
30 after surgery. This was also true for all mitochondrial
respiratory chain complexes.
At day 10 (n ¼ 9), V0 was 2.05  1.01 versus
3.57  1.02 mmol/L O2/minute/g dry weight (dw) (p < .01)
in ischemic and control legs, respectively. Vmax was
6.97  2.41 versus 10.29  2.02 mmol O2/minute/g dw
(p < .01). Complex II, III, and IV activity (Vamytal) was
4.32  1.84 versus 6.87  1.46 mmol/L O2/minute/g dw
(p < .01). Finally, complex IV activity (Vtmpd) was
8.27  2.47 versus 11.01  2.60 mmol/L O2/minute/g dw
(p < .01) in ischemic and control legs, respectively.
Figure 1. (A) Clinical, (B) functional and (C) perfusion scores are
impaired after induction of ischemia. Day 10, n¼ 26; day 20; n¼ 17,
day 30, n ¼ 9. Mean  SD at days 0, 4, 6, 10, 20, and 30.
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3.26  0.41 mmol/L O2/minute/g dw (p < .01); Vmax was
7.30  1.59 versus 9.86  1.44 mmol/L O2/minute/g dw
(p < .01); Vamytal was 4.64  1.23 versus 6.03  1.05 mm/L
O2/min/g dw (p < .01) and Vtmpd was 8.07  1.25 versus
10.25  0.93 mmol/L O2/minute/g dw (p < .01) in ischemic
and control legs, respectively.
At day 30 (n ¼ 9), V0 was 2.33  0.70 versus
3.34  0.84 mmol/L O2/minute/g dw (p ¼ .01) in ischemic
and control legs, respectively. Vmax was 7.93  0.99 versus
10.09  2.87 mmol O2/minute/g dw (p ¼ .01). Complex II,
III, and IV activity (Vamytal) was 4.99  0.58 versus
6.45  2.39 mmol/L O2/minute/g dw (p ¼ .06). Finally,
complex IV activity (Vtmpd) was 8.68  1.18 versus
10.36  2.02 mmol/L O2/min/g dw (p ¼ .04) in ischemic
and control legs, respectively (Fig. 2A).
CRC. CRC was also impaired in ischemic muscles compared
with control muscles: 7.3  1.2 versus 10.6  1.2 mM/mg
dw for the nine mice sacriﬁced at day 10 (p < .01).
At day 20 (n ¼ 8), CRC was 20 6.8  0.9 mmol/L mg dw
versus 11.4  0.7 mmol/L mg dw (p < .01).
At day 30 (n ¼ 9), CRC was 7.4  1.6 mmol/L mg dw
versus 11.9  0.9 mmol/L mg dw (p < .01) in ischemic and
control legs, respectively (Fig. 2B).
Production of ROS using electron paramagnetic resonance
and DHE staining. Production of free radicals was increased
in ischemic gastrocnemius compared with control muscles:
0.089  0.033 versus 0.080  0.022 mmol/L min/mg dw for
the nine mice sacriﬁced at day 10 (p ¼ .46); 0.102  0.024
versus 0.083  0.034 mmol/L min/mg dw for the eight mice
sacriﬁced at day 20 (p ¼ .01); and 0.084  0.029 versus
0.051  0.031 mmol/L min/mg dw for the nine mice
sacriﬁced at day 30 (p ¼ .03). Fluorescence after DHE
staining was also higher in ischemic tibialis ﬁbers:
3622  604 arbitrary units of ﬂuorescence (AUFs) versus
1224  324 AUFs (p < .01) (Fig. 3A, B).
Histological analysis: muscle structure. Chronically ischemic
tibialis muscle exhibited myopathic features, as established
by hemotoxylin and eosin coloration with a wider range in
ﬁber size, a more rounded shape, centrally located nuclei,
and smaller cross-sectional areas than control ﬁbers (Fig. 3C).
Stability of the model over time. As shown in Fig. 1, clinical,
functional, and scintigraphic parameters were similar in the
control leg at days 10, 20, and 30 after surgery. Importantly,
impairments in ischemic legs were also stable during the
study follow-up.
Mitochondrial respiration, CRC, and production of free
radicals showed a similar evolution, demonstrating the sta-
bility of the model (Fig. S1; see Supplementary Information).
Transcripts encoding proteins involved in mitochondrial
biogenesis and antioxidant defense. RNA analysis revealed
a decrease in biogenesis, with a decrease in PGC-1a of 63%
(p¼ .01), 44% (p¼ .01), and 41% (p¼ .04) at days 10, 20, and
30, respectively; a decrease in PGC-1b of 60% (p¼ .01), 36%
Figure 2. (A) Mitochondrial respiration and (B) calcium retention capacity are decreased after induction of ischemia. Note. V0 ¼ basal
mitochondrial oxydative capacity; Vmax ¼ maximal mitochondrial oxidative capacity; Vamytal ¼ complex II, III, and IV activity;
Vtmpd ¼ complex IV activity. *p < .05; **p < .01; ***p < .001.
Murine Model of Chronic Limb Ischemia 209(p ¼ .03), and 49% (p ¼ .01) at days 10, 20, and 30, respec-
tively; and a decrease in NRF1 of 19% (p¼ .04), 35% (p¼ .02)
and 41% (p ¼ .02) at days 10, 20, and 30, respectively.
The antioxidant system was impaired at days 10, 20,
and 30: SOD1 was decreased by 39% (p ¼ .01), 44%(p ¼ .01), and 32% (p ¼ .04), respectively; SOD2 by 59%
(p ¼ .01), 38% (p ¼ .04), and 41% (p ¼ .02), respectively;
and catalase by 60% (p ¼ .01), 36% (p ¼ .04), and 49%
(p ¼ .03), respectively (Fig. S2; see Supplementary
Information).
Figure 3. Oxidative stress is increased after induction of ischemia and chronic limb ischemia leads to myopathic features. (A) Dihy-
droethidium stain. (B) Production of free radicals. (C) Hematoxylin and eosin stain.
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A sustainable and stable-over-time model of CLI, according
to TASC II guidelines, has been developed with clinical signs,conﬁrmation of hypoperfusion by objective measures,
lasting for more than 2 weeks, and using sequential artery
ligations. Models already used in order to induce ischemia
Murine Model of Chronic Limb Ischemia 211are based on a single arterial ligation. In rodents, ligation of
the femoral artery just distal to the origin of the profunda
femoris is most commonly used.11e14,18,19 However, this
method leaves most of the collateral circulation to the
lower limb intact and, consequently, blood ﬂow to the limb
is fully restored within 7 days.19 Another method consists of
total excision of the femoral artery, removing the collateral
bed. However, blood ﬂow is restored progressively, with a
third of the original blood ﬂow restored only 7 days after
excision of the femoral artery. In fact, collateral vessels in
the mice arise mostly from the internal iliac artery.20 By
performing sequential ligations in the CLI model presented
herein, a sustainable ischemia was obtained, likely because
the second ligation performed on the common iliac artery
reduces the collateral perfusion provided by the internal
iliac artery.
Herein, a new CLI model is proposed, which fulﬁlls all
criteria deﬁning CLI. In order to diagnose CLI, current rec-
ommendations require that both clinical signs and symp-
toms are present for >2 weeks along with objective
measurements of arterial perfusion.4 Using already-
established clinical scores and MIBI scintigraphies, it has
been demonstrated that the present model fully complies
with these recommendations. While clinical scores are not
routinely used when characterizing animal models, they
can, nevertheless, be easily transposed as animals also
present with several degrees of lower limb impotency and,
moreover, the observed tissue lesions follow the same
pattern as in humans, ranging from a cyanotic aspect of the
limb to necrosis. Also, rather than using invasive arteriog-
raphy, scintigraphy was preferentially used, as it has already
been proven to be a good approach for cardiac or skeletal
muscle perfusion studies.21e23 Indeed, such a noninvasive
technique enables potential perfusion changes to be fol-
lowed over time. Furthermore, Tc-99m MIBI scintigraphy
can detect hypoperfusion earlier than with laser Doppler
imaging, as the uptake of this radiopharmaceutical com-
pound is dependent on the distribution of regional blood
ﬂow, an early indicator of hypoperfusion.22 Currently, MIBI
scintigraphies are under consideration for the study of pe-
ripheral arterial disease (PAD).23 Finally, in the present
study, particular care was taken to follow the animals until
30 days after the ﬁrst surgical ligation, thus allowing
assessment of the observed symptoms and hypoperfusion
for a period of >2 weeks.4
The pathophysiology of lower limb ischemiaereperfusion
has been largely improved in recent years and, as a result,
key mechanisms, such as muscle mitochondrial function
and oxidative stress, were further investigated. Given that
mitochondrial dysfunction and increased oxidative stress
are largely involved in acute lower limb ischemia, whether
these elements are also key factors in CLI was investi-
gated.24e26 Accordingly, in our CLI model, ischemic murine
muscles displayed impaired mitochondrial respiration
involving all mitochondrial respiratory chain complexes.
Furthermore, early Caþþ release in the ischemic muscle was
also observed herein. These data support that chronically
ischemic muscles are prompt to apoptose. Finally,mitochondrial dysfunctions were associated with a reduced
mitochondrial biogenesis, which also probably participated
in the chronic alteration of ischemic muscles. Mitochondria
may potentially be both actors and targets in chronic
ischemiaereperfusion-related injuries as they both enhance
and are impaired by ROS production. A reduction in anti-
oxidant capacities was also observed, as mRNA encoding
SOD1 and SOD2, and catalase, the main enzymes involved
in ROS detoxiﬁcation, were signiﬁcantly decreased in
ischemic muscles. Pipinos et al.8 observed that ischemic
human muscles presented mitochondrial alterations and
exhibited myopathic features, with ischemic myoﬁbers
demonstrating a broader range in terms of size, a more
rounded shape, centrally located nuclei, and smaller cross-
sectional area than control ﬁbers. In the CLI model pre-
sented herein, mitochondrial alterations and myopathic
features of ischemic myoﬁbers also mimic human
pathology.
However, despite its wide similitude with human pa-
thology, this model has limitations. First, human CLI
generally occurs on already pathological arteries linked to
cardiovascular risk factors and comorbidities associated to
PAD. Thus, CLI is a result of a chronic process associated
with the build-up of atherosclerotic plaque over many years
leading to arterial stenosis. Here, sequential ligations are
performed on healthy arteries. Further, CLI pathogenesis in
humans develops gradually at multiple and different loca-
tions (iliac arteries, superﬁcial femoral arteries). These
obliterations are progressive, and not acute, as were the
ligations done in the model. However, as in PAD, sequential
ligations likely allowed neoangiogenesis and collaterality,
leading mainly to hypoperfusion rather than to complete
acute ischemia of the limb. Thus, sequential ligations fairly
mimic the progressivity of PAD, until a threshold of hypo-
perfusion causing CLI.18
In conclusion, the present study shows that sequential
artery ligations lead to a valid CLI model based on both
in vivo (clinical, functional and perfusion scores) and ex vivo
(mitochondrial respiration, biogenesis, CRC and oxidative
stress) impaired functions. Although needing to be tested in
other mice strands demonstrating, for instance, cardiovas-
cular risk factors, this experimental model would likely help
to better investigate efﬁcient therapeutic strategies to be
later proposed in patients with CLI.
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